Houston Cosmetic Surgeon
Texas Plastic Surgery

Home > Articles > Conclusions

	First Name Last Name Email Please select a procedure... Blepharoplasty Botox Browlift Cheek implants Cheek Lift Chin implant Dermabrasion Face Lift Facial liposuction Hair Transplantation Laser Hair Removal Laser Skin resurfacing Lip Augmentation Neck Liposuction Otoplasty Relaxed Expressions Rhinoplasty Tattoo Removal Wrinkle Fillers How did you hear about us? Contact us form Event Google Magazine MSN Newsletter Radio Word Of Mouth Yahoo Television Real Self Sign up for newsletter Special Offers Upcoming Events
	Before & After Photos
	Dr. Kridel in Vogue Magazine, where he was the only facial plastic surgeon noted for Texas. Dr. Kridel voted top doc for women by H Texas Magazine. Dr. Kridel named as a Super Doctor in Texas Monthly Magazine.

Corection of the Soft Tissue Pollybeak Using Triamcinolone Injection Page 01 Page 02 Page 03 Page 04 Page 05 Page 06

Because revision surgery is difficult and may result in complications, subcutaneous intralesional triamcinolone injection is the first-line tratment for the soft tissue polybeak deformity. The technique is straightforward, and good results may be achieved. Subcutaneous injections into scar tissue may be accompanied by infrequent adverse effects, most commonly subcutaneous atrophy; therefore, injections should be administered only in the subcutaneous level of supratip, where the overlaying skin is thick. Should intralesional steroid injection fail to satisfactory treat the deformity, revision rhinoplasty can still be performed at 6 moths after the initial surgery.

Accepted for publication August 23,2000.
This study was presented in part at the spring meeting of the American Academy of Facial Plastic and Reconstructive Surgery (Combined Otolaryngological Spring Meetings), Orlando, Fla, May 13, 2000.
Corresponding authors and reprints: Russell W. H. Kridel, MD, Facial Plastic Surgery Associates, 6655 Travis St, Suite 900, Houston, TX 77030-1336 (e-mail: rkridel@todaysface.com).

REFERENCES

1. Holt GR, Garner ET, McLarey D. Postoperative sequelae and complications of rhinoplasty. Otolaryngol Clin North Am. 1987;20:853-876.
2. Parkes ML, Kanodia R, Machida BK. Revision rhinoplasty: an analysis of aesthetic deformities. arch Otolaryngol Head Neck Surg. 1992;118:695-701.
3. Swanwpoel PF, Eisenberg I. Current concepts in cosmetic rhinoplasty. S Afr Med J. 1981;60:536.
4. cook TA, Guida RA. Postoperative management of rhinoplasty patients. In Daniel RK, ed. Rhinoplasty. Boston, Mass: Little Brown & Co Inc; 1993:769-776.
5. Wright WK. Symposium: the supra-tip in rhinoplasty: a dilemma, II: influence of surrounding structure and prevention. Laryngoscope. 1976;86:50-52.
6. Rees TD. An aid to the tratment of supratip swelling after rhinoplasty. Laryngoscope.1971;81:308-311.
7. Mahe E, Camblin J, Micheli Pelligrini V. Les injections dácetonide de triamcinolone dans le traitement du "bec de corbin." Ann Otolaryngol Cher Cervocofac. 1974;91:695-703.
8. Mahe E, Camblin J, Micheli Pelligrini V. Traitment du "bec de corbin" postoperatoire par injections iteratives in situ d'acetonide de triamcinolone. ann Chir Plast. 1979;29:79-86.
9. Guyuron B, DeLuca L, Lash R. Supratip deformity: a closer look. Plast Recontr Surg. 2000;105:1140-1151.
10. Gruber RP. Supratip deformity : a closer look. Plast Recontr Surg. 2000;105:1152-1153.
11. Maguire HC Jr. Tratment of keloids with triamcinolone acetonide injected intralesionally. JAMA.1965;192:325-326.
12. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars a ten year follow up study. Br. J Plast Surg. 1992;45:374-379.
13. Lindsey WH, David PT. Facial keloids: a 15-year experience. Arch Otolaryngol Head Neck Surg. 1997;123:397-400.
14. Ceilley RI, Babin RW. The combined use of cryosurgery and intralesional injections of susopensions of fluorinatedadrenocorticosteroids for reducing keloids and hypertrophic scars. J Dermatol Surg Oncol. 1979;5:54-56.
15. Cohen IK, Diegelmann RF. The biology of keloids and hypertrophic scars and the influence of corticosteroids. Clin Plast Surg. 1977;4:294-299.
16. Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids: a collective review. Plast Recontr Surg. 1974;53:140-154.
17. Bojadjiev C, Popchristova E, Mazgalova J. Histomorphologic changes in keloids treated with Kenacort. J Trauma. 1995;38:299-302.
18. Shafir R, Cohen M, Gur E. Blindness as a complication of subcutaneous nasal steroid injection. Plast Reconstr Surg. 1999;104:1180-1182.
19. Mabry RL. Visual loss after intranasal corrticosteroid injection: incidence, causes, and prevention. Arch Otolaryngol. 1981;107:484-486.
20. Mabry RL. Evaluation of systemic absorption or intraturbinally injected triamcinolone. Otolaryngol Head Neck Surg. 1981;89:268-270.
21. Kittel H, Masing H. Corticosteroid therapy in rhinoplasty. Rhinology. 1976;14:163-166.
22. Hoffmann DF, Cook TA, Quatela VC, Wang TD, Brownrigg PJ, Brummett RE. Steroids and rhinoplasty: a double-blind study. Arch Otolaryngol Head Neck Surg. 1991;117:990-993.
23. Cruz NI, Korchin L. Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg. 1994;33:401-405.
24. Berman B, Flores F. The treatment of hypertrophic scars and keloids. Eur J Dermatol. 1998;8:591-596.
25. Chau D, Mancoll JS, Lee S, Zhao J, Phillips LG, Gittes GK, Longaker MT. Tamoxifen downregulates TGF.beta production in keloid production fibroblasts. Ann Plast Surg. 1998; 40:490-493.